. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public
financial statements (Thousand Bath) 30 Jun 19 % 30 Jun 18 % YOY %YOY Sales 370,857 70.66% 308,181 76.55% 62,676 20.34% Service income 48,880 9.31% 45,767 11.37% 3,113 6.80% Other income 105,131 20.03% 48,651
Microsoft Word - NWR 75-61_E_Q1 (Translation) No.FN-NWR 075/61 15 May 2018 Subject : Submission of Financial Statements for the first quarter ended March 31,2018 To : President The Stock Exchange of
Plc. would like to inform the financial results for the third quarter of 2018 which ended on 30 September 2018. The Company and its subsidiary reported a net profit of THB 1.39 million or earnings per
Fortune Parts Industry Public Company Limited (“FPI” or “The Company”) would like to submit the annual financial statements for the three-month period ended 30 June 2020 which has been audited by certified
consolidated financial statement For the three-month period (July 1, 2017 – September 30, 2017) Unit : Million Baht 2017 2016 Revenue from sale and rendering of services (excluded Fuel Cost) 1,768.59 1,368.21
strictly cost control. In addition, some expenses were recorded as finance costs due to the adoption of TFRS No.9 Financial Instrument and TFRS No. 16 Leases since 2020. 6. Administrative expense was THB
MB in the year 2017) mainly decreased from travelling expenses and consultation fee etc. Finance Cost In the year 2018, the Company and its subsidiaries had the financial cost 8.2 MB decreased 12.5
, there was an additional depreciation calculated by the investment in assets used in production to boost efficiency and reduce production costs in the long run. - In the consolidated financial statements
financial status as at 31 December 2021 (Unit: Million Baht) Assets 31 Dec. 2021 % 31 Dec. 2020 % Trade and other receivables 478.68 24% 471.67 23% Inventories 152.25 8% 125.97 7% Lease receivable 75.88 4